A global biopharmaceutical company had previously conducted an internal AI assessment to evaluate the maturity of its processes in this emerging field, which helped identify a number of gaps.
The most pressing was the absence of an AI governance framework.
It was clear that plugging this gap was a vital needed step that was essential if it was to harness successfully the potential of AI
It was also clear that this was also necessary to ensure risk mitigation